Servier Pharmaceuticals · 9 hours ago
Vice President, US Market Access
Boston, MA
Full-time
Hybrid
Director/Executive
20+ years expServier Pharmaceuticals is a Boston-based biopharmaceutical company focused on advancing cutting-edge science. The VP, US Market Access will lead the development and execution of Market Access strategies to ensure optimal patient access for Servier’s products in the U.S. market, while collaborating with cross-functional teams to meet corporate objectives.
Health CareMedicalPharmaceutical
Responsibilities
Create a vision and strategic plan for the US Market Access organization in alignment with Servier’s corporate and commercial objectives
Lead, mentor, and develop a high-performing Market Access organization across multiple functions, including: National Accounts, Government Pricing & Contracting, Trade & Distribution, Managed Care Marketing, and Patient Services
Understand and stay abreast of the complex and ever-changing U.S. payer and channel landscape; assess challenges and impact on the Company’s current and future portfolio
Participate in key corporate governance committees and leadership forums to provide Market Access expertise and drive key decisions (i.e. pricing strategy and Business Development valuations)
Collaborate with Sales and Marketing leadership and other members of the Commercial Leadership Team to define and implement Commercial brand strategy and tactics to meet topline demand and net revenue targets
Ensure all programs, activities and engagements adhere to legal, regulatory, and ethical standards
Qualification
Required
The successful candidate will be required to have a BS/BA, and a Masters degree is preferred
20+ years of experience with proven leadership and direction of a team responsible for all aspects of Market Access; extensive subject matter expertise and experience in U.S. Market Access, with a track record of delivering highly successful and value-added market access solutions in the oncology arena
Well-developed, strategic business acumen and extensive knowledge of the U.S. public and private payer environment, the impact of health care reform and payer trends, and the U.S. distribution channel environment and emerging trends
Thorough understanding of the pharmaceutical industry regulatory environment related to pricing, contracting, and Market Access programs
Expertise spanning all channels in the value chain including payer, provider and distributor as well as an understanding of how strategic choices affect overall company/product strategy and investment in both the short and long term
Demonstrated experience leading market access teams across all key functional areas including reimbursement, pricing/contracting, commercial account management, government policy, and government account management
Leads by example; an ability to attract and develop talent, build interdependent partnerships and create a culture of collaboration and teamwork that fosters open communication, constructive conflict resolution and organizational flexibility
Ability to operate effectively and lead teams in changing environment; create and execute business plans/innovative strategies
A current understanding and appreciation for the implications of trends and government reforms that will impact market access strategies
Preferred
A Masters degree is preferred
Company
Servier Pharmaceuticals
Servier Pharmaceuticals is a pharmaceutical company dedicated to therapeutic progress to serve patient needs.
201-500 employees
H1B Sponsorship
Servier Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (4)
2023 (4)
2022 (3)
2021 (15)
2020 (2)
Funding
Current Stage
Growth StageLeadership Team
David K. Lee
Chief Executive Officer
Pedro Crisanto
Chief Operating Officer R&D, USA
Recent News
2025-12-08
Company data provided by crunchbase